Graphite Bio

About:

Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.

Website: https://graphitebio.com

Top Investors: Fidelity, Deerfield, RA Capital Management, OrbiMed, Perceptive Advisors

Description:

Graphite Bio is a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases. Graphite Bio is pioneering a precision gene editing approach that could enable a variety of applications to transform human health through its potential to achieve one of medicine’s most elusive goals: to precisely “find & replace” any gene in the genome. Graphite Bio’s platform allows it to precisely correct mutations, replace entire disease-causing genes with normal genes or insert new genes into predetermined, safe locations.